Replies to post #203410 on Bioelectronics Corp (BIEL)

[markjohn62]

I like the feel of this update more than past ones. Possibly seeing CE mark restoration before the end of the year would be a great Christmas present in my book. A change in culture is much needed. It starts with no glaring typos in shareholder updates. I'd like to see a website that is up to date. When people look for information, online is the first look people will likely have. As they say, "You don't get a second chance to make a first impression. A quick deal with Dr. Scholls (If that is who they talked to)would be be the fire starter. That would be a marketed product with with an established world leader. IMO, that is the smallest market as an indication. Even if the margins were low, it would be worth it for the legitimization effect to the product line.

[srinsocal]

"This program is set to launch late in the first quarter of 2020"

<<<<<This is also a wait and see, and no details were provided, so we have no real idea what this will do for BIEL! But we can speculate, which is all we ever seem to get from this company!>>>>>

No it is not a "wait and see" this is a Finalized Deal and numerous details are provided:

"One of our channel partners has finalized a deal with an American multinational health care services company to place ActiPatch in 1000 independently owned stores and launch under an initiative for alternative pain therapies. This program is set to launch late in the first quarter of 2020. Our channel partner has expertise in creating custom orthopedic appliances and has been asked by a global provider of high-quality orthopedic devices to develop a product for proposed post-operative use, and two other anatomical sites which fall under existing OTC indications."